Patent details

EP3797772 Title: REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S DISEASE

Basic Information

Publication number:
EP3797772
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP190205047
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S DISEASE
French Title of Invention:
REBAMIPIDE DESTINÉ À ÊTRE UTILISÉ DANS LA PRÉVENTION ET LE TRAITEMENT DE LA MALADIE DE CROHN
German Title of Invention:
REBAMIPID ZUR VERWENDUNG BEI DER PRÄVENTION UND BEHANDLUNG VON MORBUS CROHN
SPC Number:

Dates

Filing date:
03/09/2019
Grant date:
18/10/2023
EP Publication Date:
31/03/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/10/2023
EP B1 Publication Date:
18/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/09/2024
Expiration date:
03/09/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/10/2023
 
 

Name:
SQUARE POWER LTD
Address:
2nd Floor, 9 Chapel Place, London EC2A 3DQ, United Kingdom (GB)

Classification

IPC classification:
A61K 31/4704; A61P 1/00; A61K 31/573;

Publication

European Patent Bulletin

Issue number:
202342
Publication date:
18/10/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages